Filana Therapeutics (FLNA) Accumulated Expenses (2014 - 2023)
Filana Therapeutics' Accumulated Expenses was $7.04 million in Q2 2023, up 112.3% from $3.32 million a year earlier and up 33.5% from the prior quarter.
Powered by 
Analysis
Filana Therapeutics (FLNA) Accumulated Expenses (2014 - 2023) Analysis & Trends
At the end of FY2022, Accumulated Expenses at Filana Therapeutics came in at $2.28 million, down 18.7% from FY2021.
- Accumulated Expenses shows a five-year compound annual growth rate of 41.7% (FY2017 to FY2022).
- In earlier years, Accumulated Expenses was $2.8 million in FY2021 (+289.8%), $719,000 in FY2020 (-7.5%), $777,000 in FY2019 (+398.1%) and $156,000 in FY2018 (-60.9%).
- The Q2 2023 figure marks the highest quarterly Accumulated Expenses in data going back to Q4 2014.
- Compared with a year earlier, Accumulated Expenses was higher in seven of the last eight quarters, with growth averaging 136.9%.
- The best year-over-year quarter for Accumulated Expenses over five years was Q3 2021 (growth of 482.6%); the worst was Q4 2018 (a decline of 60.9%).
- Per Business Quant data, FLNA's Accumulated Expenses in the three quarters before Q2 2023 was $5.28 million (Q1 2023), $2.28 million (Q4 2022) and $4.1 million (Q3 2022).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,163.39 Bn | 1,131.97 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 634.39 Bn | 552.91 Bn | 17.26 Bn |
| 3 | AbbVie | 502.68 Bn | 475.79 Bn | 12.70 Bn |
| 4 | Merck | 377.37 Bn | 331.74 Bn | 12.21 Bn |
| 5 | Novartis Ag | 303.41 Bn | 267.40 Bn | 11.24 Bn |
| 6 | Astrazeneca | 266.55 Bn | 240.24 Bn | 12.86 Bn |
| 7 | Amgen | 240.56 Bn | 195.96 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 193.19 Bn | 167.38 Bn | 6.22 Bn |
| 9 | Pfizer | 172.14 Bn | 118.78 Bn | 10.94 Bn |
| 10 | Filana Therapeutics | 32.16 Mn | -338.68 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | 7.04 Mn |
| Mar 31, 2023 | 5.28 Mn |
| Dec 31, 2022 | 2.28 Mn |
| Sep 30, 2022 | 4.10 Mn |
| Jun 30, 2022 | 3.32 Mn |
| Mar 31, 2022 | 2.93 Mn |
| Dec 31, 2021 | 2.80 Mn |
| Sep 30, 2021 | 3.25 Mn |
| Jun 30, 2021 | 2.46 Mn |
| Mar 31, 2021 | 1.55 Mn |
| Dec 31, 2020 | 719,000.00 |
| Sep 30, 2020 | 558,000.00 |
| Jun 30, 2020 | 755,000.00 |
| Mar 31, 2020 | 387,000.00 |
| Dec 31, 2019 | 777,000.00 |
| Sep 30, 2019 | 415,000.00 |
| Jun 30, 2019 | 179,000.00 |
| Mar 31, 2019 | 243,000.00 |
| Dec 31, 2018 | 156,000.00 |
| Mar 31, 2018 | 18,000.00 |
API Access
Filana Therapeutics Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=FLNA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "FLNA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=FLNA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();